Livistona chinensis seed suppresses hepatocellular carcinoma growth through promotion of mitochondrial-dependent apoptosis

Oncology Reports

Volumn 29, Issue 5, 2013, Pages 1867-1872

  Lin, Wei ^a   Zhao, Jinyan ^a   Cao, Zhiyun ^a   Zhuang, Qunchuan ^a   Zheng, Liangpu ^a   Cai, Qiaoyan ^a   Chen, Daxin ^a   Wang, Lili ^a   Hong, Zhenfeng ^a   Peng, Jun ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Hepatocellular carcinoma; Herbal medicine; Livistona chinensis seed; Mitochondrion

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; LIVISTONA CHINENSIS EXTRACT; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARECACEAE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL LOSS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVISTONA CHINENSIS; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PLANT SEED; PRIORITY JOURNAL; TOXICITY TESTING; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; HEPG2 CELL LINE; LIVER NEOPLASMS; METABOLISM; MITOCHONDRION; NUDE MOUSE; RANDOMIZATION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; ARECACEAE; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOCHONDRIA; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; SEEDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84895695122     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2319     Document Type: Article

References (36)

1. Gomaa A, Khan S, Toledano M, Waked I and Taylor-Robinson S: Hepatocellular carcinoma: epidemiology, risk factors and patho genesis. World J Gastroenterol 14: 4300-4308, 2008.
2. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A and Castagnetta LA: Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann NY Acad Sci 963: 13-20, 2002.
3. Sherman M: Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis 25: 143-154, 2005.
4. Parkin D, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
5. Yeh C, Chen T, Chang M, Hsu C and Yeh T: Identification of NV-F virus DNA in hepatocellular carcinoma. J Med Virol 79: 92-96, 2007.
6. Levin B and Amos C: Therapy of unresectable hepatocellular carcinoma. N Engl J Med 332: 1294-1296, 1995.
7. Abou-Alfa G, Huitzil-Melendez F, O'Reilly E and Saltz L: Current management of advanced hepatocellular carcinoma. Gastrointest Cancer Res 2: 64-70, 2008.
8. Boose G and Stopper H: Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol Lett 116: 7-16, 2000.
9. Gordaliza M: Natural products as leads to anticancer drugs. Clin Transl Oncol 9: 767-776, 2007.
10. Newman D, Cragg G and Snader K: The influence of natural products upon drug discovery. Nat Prod Rep 17: 215-234, 2000.
11. Adams J and Cory S: The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337, 2007.
12. Cory S and Adams J: The Bcl-2 family: regulators of the cellular life-of-death switch. Nat Rev Cancer 2: 647-656, 2002.
13. Reed J: Mechanisms of apoptosis. Am J Pathol 157: 1415-1430, 2000.
14. Borner C: Bcl-2 family members: integrators of survival and death. Biochim Biophys Acta 1644: 71-72, 2004.
15. Vaux D and Korsmeyer S: Cell death in development. Cell 96: 245-254, 1999.
16. Gross A, McDonnell J and Korsmeyer S: Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
17. Hsu Y, Wolter K and Youle R: Cytosol to membrane redistribution of members of the Bcl-2 family during apoptosis. Proc Natl Acad Sci USA 94: 3668-3672, 1997.
18. Wolter K, Hsu YT, Smith CL, Nechushtan A, Xi XG and Youle RJ: Movement of Bax from the cytosol to mitochondria. J Cell Biol 139: 1281-1292, 1997.
19. Tan C, Dlugosz PJ, Peng J, Zhang Z, Lapolla SM, Johnson AE, Andrews DW and Lin J: Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2. J Biol Chem 281: 14764-14775, 2006.
20. Antonsson B, Montessuit S, Lauper S, Eskes R and Martinou JC: Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochon dria. Biochem J 345: 271-278, 2000.
21. Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D and Reed JC: Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95: 4997-5002, 1998.
22. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
23. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI and Jones DP: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
24. Thomenius MJ, Wang NS, Reineks EZ, Wang Z and Distelhorst CW: Bcl-2 on the endoplasmic reticulum regulates Bax activity by binding to BH3-only proteins. J Biol Chem 278: 6243-6250, 2003.
25. Youle RJ and Strasser A: The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59, 2008.
26. Yip KW and Reed JC: Bcl-2 family proteins and cancer. Oncogene 27: 6398-6406, 2008.
27. Zhao G, Dai S and Chen R: Dictionary of traditional Chinese medicine. Shanghai Scientific and Technical Publishers. Vol 2, pp2459-2460, 2006.
28. Cheueng S and Tai J: In vitro studies of the dry fruit of Chinese fan palm Livistona chinensis. Oncol Rep 5: 1331-1336, 2005.
29. Sartippour MR, Liu C and Shao ZM: Livistona extract inhibits angiogenesis and cancer growth. Oncol Rep 6: 1355-1357, 2001.
30. Wen CH, Rae MH and Lang MC: Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown. Cancer Lett 248: 137-146, 2007.
31. Wang H, Li A, Dong XP and Xu XY: Screening of anti-tumor parts from the seeds of Livistona chinensis and its anti-angiogenesis effect. Zhong Yao Cai 315: 718-722, 2008 (In Chinese).
32. Cai Q, Lin J, Wei L, Zhang L, Wang L, Zhan Y, Zeng J, Xu W, Shen A, Hong Z and Peng J: Hedyotis diffusa willd inhibits colorectal cancer growth in vivo via inhibition of STAT3 signaling pathway. Int J Mol Sci 13: 6117-6128, 2012.
33. Wei L, Lin J, Xu W, Cai Q, Shen A, Hong Z and Peng J: Scutellaria barbata D. don inhibits tumor angiogenesis via suppression of hedgehog pathway in a mouse model of colorectal cancer. Int J Mol Sci 13: 9419-9430, 2012.
34. Mantymaa P, Siitonen T, Guttorm T, Saily M, Kinnula V, Savolainen ER and Koistinen P: Induction of mitochondrial manganese superoxide dismutase confers resistance to apoptosis in acute myeloblastic leukaemia cells exposed to etoposide. Br J Haematol 108: 574-581, 2000.
35. + cell line KG-1a. Exp Hematol 31: 815-823, 2003.
36. Kitada S, Pedersen IM, Schimmer AD and Reed JC: Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene 21: 3459-3474, 2002.